MEI Pharma: MEI Pharma, Inc. Reports Earnings Results for the Full Year Ended June 30, 2024

MEI Pharma, Inc. reported earnings results for the full year ended June 30, 2024. For the full year, the company reported sales was USD 0.752 million compared to USD 48.82 million a year ago. Revenue was USD 65.3 million compared to USD 48.82 million a year ago. Net income was USD 17.78 million compared to net loss of USD 31.84 million a year ago.